Implementing the Oncology Care Model required educating physicians and staff on a new way to do the work and why the changes were necessary under the new model, explained Sibel Blau, MD, medical oncologist at Northwest Medical Specialties, PLLC.
Implementing the Oncology Care Model required educating physicians and staff on a new way to do the work and why the changes were necessary under the new model, explained Sibel Blau, MD, medical oncologist at Northwest Medical Specialties, PLLC.
Transcript
How were you educating physicians and staff on the Oncology Care Model?
There were general meetings, big meetings, that provided a general overview. But most of it was done mainly by patient care coordinators and case managers talking to the individuals and giving the education and the focused parts of their workload and how it affects what they do, how that affects the whole model.
For example, the [medical assistants] had to do the medicine reconciliation in the way that it was never perfect, and telling them that, “Hey, you have to do this,” is not enough, you have to say why you have to do this. And that was always a part of it. In the context of we’re doing value-based care, Oncology Care Model requires this. A lot of times it was that people understand for a while and they get rebellious or they get upset: “Why do I have to do this redundant work?”
Especially providers, because it puts a lot on them on trying to record things in the [electronic medical record]. And you have to just sometimes say, “This is the new model, this is where we’re going, this is a change that’s going to take time.” Sometimes it’s hard to explain everything. Sometimes you don’t even understand it perfectly yourself. It is the way it is. We have to do this. That was the last part of this whole education, trying to transform the practice piece.
There was also education on the patient’s part, which is very difficult to do. You have to develop a separate system starting with the patient care upfront. When they come into the clinic, you have to start explaining to them, “We’re doing something different; we are a medical home. We’re going to be treating you with your cancer, but also we have to give you the opportunity to provide the best care to you by working with us.” And that requires patient compliance and attendance to this, as well.
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
Early Detection Strategies for Interstitial Lung Disease in Rheumatology: Janet Pope, MD, MPH
August 11th 2025Janet Pope, MD, MPH, discusses screening and diagnostic approaches for interstitial lung disease in patients with systemic sclerosis, rheumatoid arthritis, and other connective tissue diseases.
Read More
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More